Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder
Clinical trial registration, sponsored by Clive Michelsen, registered 13 Oct 2026.
Phase 1/Phase 2 · not yet recruiting · n = 60
Tags: Registry, Ibogaine, Addiction.
Newly registered: medically supervised ibogaine versus extended-release naltrexone for opioid use disorder, single site, with 12-month digital support
How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)
Read the original
